MarketBeat Instant News Alerts 2 hours agoAktis Oncology (NASDAQ:AKTS) Receives Average Rating of "Moderate Buy" from AnalystsMarketBeatShares of Aktis Oncology (NASDAQ:AKTS - Get Free Report) have received a consensus rating of "Moderate Buy" from the ten analysts that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and onNASDAQ:AKTSRead Aktis Oncology (NASDAQ:AKTS) Receives Average Rating of "Moderate Buy" from Analysts2 hours agoSOLV Energy Inc. (NASDAQ:MWH) Given Consensus Recommendation of "Moderate Buy" by AnalystsMarketBeatShares of SOLV Energy Inc. (NASDAQ:MWH - Get Free Report) have been assigned an average rating of "Moderate Buy" from the thirteen research firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a holdNASDAQ:MWHRead SOLV Energy Inc. (NASDAQ:MWH) Given Consensus Recommendation of "Moderate Buy" by Analysts2 hours agoWebull Corporation (NASDAQ:BULL) Given Average Rating of "Moderate Buy" by AnalystsMarketBeatShares of Webull Corporation (NASDAQ:BULL - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the five ratings firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has assigned a hold ratinNASDAQ:BULLRead Webull Corporation (NASDAQ:BULL) Given Average Rating of "Moderate Buy" by Analysts2 hours agoAssa Abloy AB (OTCMKTS:ASAZY) Receives Average Rating of "Moderate Buy" from BrokeragesMarketBeatShares of Assa Abloy AB (OTCMKTS:ASAZY - Get Free Report) have received an average recommendation of "Moderate Buy" from the eight analysts that are covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, four have issued a buy recommendatOTCMKTS:ASAZYRead Assa Abloy AB (OTCMKTS:ASAZY) Receives Average Rating of "Moderate Buy" from Brokerages2 hours agoFirst Tracks Biotherapeutics (NASDAQ:TRAX) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesMarketBeatFirst Tracks Biotherapeutics (NASDAQ:TRAX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the eleven research firms that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendatiNASDAQ:TRAXRead First Tracks Biotherapeutics (NASDAQ:TRAX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages2 hours agoEnterprise Financial Services Corporation (NASDAQ:EFSC) Given Consensus Rating of "Moderate Buy" by AnalystsMarketBeatShares of Enterprise Financial Services Corporation (NASDAQ:EFSC - Get Free Report) have been given an average rating of "Moderate Buy" by the five research firms that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and four have giveNASDAQ:EFSCRead Enterprise Financial Services Corporation (NASDAQ:EFSC) Given Consensus Rating of "Moderate Buy" by Analysts Trending News1BlackBerry (NYSE:BB) Stock Price Up 8.8% - Here's What Happened2IREN Q4 Earnings Call Highlights3Bank of America Corp DE Has $5.78 Million Stock Position in Plug Power, Inc. $PLUG4UiPath (NYSE:PATH) Stock Price Up 8.2% - Here's Why5Marvell Technology Q2 Earnings Call Highlights6Value Aligned Research Advisors LLC Makes New $12.53 Million Investment in Fermi Inc. $FRMI715,560,453 Shares in USA Rare Earth Inc. $USAR Purchased by BlackRock Inc.8Amazon.com (NASDAQ:AMZN) Shares Down 1.5% - Here's What Happened All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoSimpson Manufacturing Company, Inc. (NYSE:SSD) Given Consensus Rating of "Hold" by BrokeragesMarketBeatNYSE:SSDRead Simpson Manufacturing Company, Inc. (NYSE:SSD) Given Consensus Rating of "Hold" by Brokerages2 hours agoAngel Oak Mortgage REIT Inc. (NYSE:AOMR) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMarketBeatNYSE:AOMRRead Angel Oak Mortgage REIT Inc. (NYSE:AOMR) Receives Consensus Recommendation of "Moderate Buy" from Analysts2 hours agoFinWise Bancorp (NASDAQ:FINW) Given Consensus Rating of "Hold" by AnalystsMarketBeatNASDAQ:FINWRead FinWise Bancorp (NASDAQ:FINW) Given Consensus Rating of "Hold" by Analysts2 hours agoOportun Financial Corporation (NASDAQ:OPRT) Given Consensus Recommendation of "Hold" by BrokeragesMarketBeatNASDAQ:OPRTRead Oportun Financial Corporation (NASDAQ:OPRT) Given Consensus Recommendation of "Hold" by Brokerages2 hours agoK-Bro Linen Inc. (TSE:KBL) Given Average Recommendation of "Buy" by AnalystsMarketBeatTSE:KBLRead K-Bro Linen Inc. (TSE:KBL) Given Average Recommendation of "Buy" by Analysts2 hours agoMorgan Stanley Begins Coverage on Attovia Therapeutics (NASDAQ:ATTO)MarketBeatNASDAQ:ATTORead Morgan Stanley Begins Coverage on Attovia Therapeutics (NASDAQ:ATTO)2 hours agoStifel Nicolaus Begins Coverage on Braveheart Bio (NASDAQ:BRVE)MarketBeatNASDAQ:BRVERead Stifel Nicolaus Begins Coverage on Braveheart Bio (NASDAQ:BRVE)2 hours agoBraveheart Bio (NASDAQ:BRVE) Now Covered by Cantor FitzgeraldMarketBeatNASDAQ:BRVERead Braveheart Bio (NASDAQ:BRVE) Now Covered by Cantor Fitzgerald2 hours agoBrainsway (NASDAQ:BWAY) Price Target Raised to $19.00 at HC WainwrightMarketBeatNASDAQ:BWAYRead Brainsway (NASDAQ:BWAY) Price Target Raised to $19.00 at HC Wainwright2 hours agoCRISPR Therapeutics (NASDAQ:CRSP) Earns Buy Rating from Needham & Company LLCMarketBeatNASDAQ:CRSPRead CRISPR Therapeutics (NASDAQ:CRSP) Earns Buy Rating from Needham & Company LLC2 hours agoCytokinetics (NASDAQ:CYTK) Earns Buy Rating from HC WainwrightMarketBeatNASDAQ:CYTKRead Cytokinetics (NASDAQ:CYTK) Earns Buy Rating from HC Wainwright2 hours agoFiserv (NASDAQ:FISV) Given "Neutral" Rating at Cantor FitzgeraldMarketBeatNASDAQ:FISVRead Fiserv (NASDAQ:FISV) Given "Neutral" Rating at Cantor Fitzgerald2 hours agoGain Therapeutics' (GANX) Buy Rating Reiterated at HC WainwrightMarketBeatNASDAQ:GANXRead Gain Therapeutics' (GANX) Buy Rating Reiterated at HC Wainwright2 hours agoGitLab (NASDAQ:GTLB) Price Target Raised to $50.00MarketBeatNASDAQ:GTLBRead GitLab (NASDAQ:GTLB) Price Target Raised to $50.002 hours agoBTIG Research Issues Positive Forecast for GitLab (NASDAQ:GTLB) Stock PriceMarketBeatNASDAQ:GTLBRead BTIG Research Issues Positive Forecast for GitLab (NASDAQ:GTLB) Stock Price2 hours agoIonis Pharmaceuticals' (IONS) "Buy" Rating Reiterated at HC WainwrightMarketBeatNASDAQ:IONSRead Ionis Pharmaceuticals' (IONS) "Buy" Rating Reiterated at HC Wainwright2 hours agoMongoDB (NASDAQ:MDB) Price Target Raised to $540.00 at Cantor FitzgeraldMarketBeatNASDAQ:MDBRead MongoDB (NASDAQ:MDB) Price Target Raised to $540.00 at Cantor Fitzgerald2 hours agoMaplight Therapeutics (NASDAQ:MPLT) Price Target Lowered to $43.00 at Needham & Company LLCMarketBeatNASDAQ:MPLTRead Maplight Therapeutics (NASDAQ:MPLT) Price Target Lowered to $43.00 at Needham & Company LLC2 hours agoNeedham & Company LLC Raises Revolution Medicines (NASDAQ:RVMD) Price Target to $275.00MarketBeatNASDAQ:RVMDRead Needham & Company LLC Raises Revolution Medicines (NASDAQ:RVMD) Price Target to $275.002 hours agoSabra Healthcare REIT (NASDAQ:SBRA) Stock Price Expected to Rise, Robert W. Baird Analyst SaysMarketBeatNASDAQ:SBRARead Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Expected to Rise, Robert W. Baird Analyst Says2 hours agoScribe Therapeutics (NASDAQ:SCTX) Now Covered by Analysts at HC WainwrightMarketBeatNASDAQ:SCTXRead Scribe Therapeutics (NASDAQ:SCTX) Now Covered by Analysts at HC Wainwright2 hours agoAndersen Group (NYSE:ANDG) Price Target Raised to $64.00MarketBeatNYSE:ANDGRead Andersen Group (NYSE:ANDG) Price Target Raised to $64.002 hours agoBabcock (NYSE:BW) Now Covered by Analysts at Needham & Company LLCMarketBeatNYSE:BWRead Babcock (NYSE:BW) Now Covered by Analysts at Needham & Company LLC2 hours agoEdison International (NYSE:EIX) Given "Neutral" Rating at MizuhoMarketBeatNYSE:EIXRead Edison International (NYSE:EIX) Given "Neutral" Rating at Mizuho Featured Articles and OffersVisa Just Put Hims & Hers in the Penalty Box—Here’s Why It MattersBy Jeffrey Neal Johnson | August 24, 2026Trump's New DollarFrom Porter & Company (Ad)Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-RaiseBy Thomas Hughes | August 26, 2026Strike a Balance Between Growth and Stability With These 3 Names Ready to RallyBy Nathan Reiff | August 30, 2026BlackRock Inc. Buys 31,939,194 Shares of Plug Power, Inc. $PLUGBy MarketBeat | August 25, 2026Ready to give options a try? Your first trade (Ticker included) -INSIDEFrom Base Camp Trading (Ad)5 Stocks to Buy in September Before Wall Street Catches OnBy Thomas Hughes | August 26, 2026Marvell Takes a Shot a Broadcom's Throne With Google DealBy Leo Miller | August 24, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 723 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
